Perfil
Ginny Blocki is currently the SVP-Product Management & Global Marketing at Embecta Corp.
Prior to this, she held positions such as Head-Global Marketing Molecular Diagnostics at Abbott Laboratories, Head-US Medication Delivery Marketing at Baxter International, Inc., SVP-Product Management & Global Marketing at Becton, Dickinson & Co., Vice President-Specialty Products at Assertio Therapeutics, Inc., and Vice President & Head-Global Marketing Immunology at Baxalta, Inc. She completed her undergraduate degree at Indiana University.
Cargos activos de Ginny Blocki
Empresas | Cargo | Inicio |
---|---|---|
EMBECTA CORP. | Sales & Marketing | 22/03/2022 |
Antiguos cargos conocidos de Ginny Blocki.
Empresas | Cargo | Fin |
---|---|---|
BECTON, DICKINSON AND COMPANY | Sales & Marketing | 01/03/2022 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/10/2021 |
BAXALTA INC | Sales & Marketing | - |
ABBOTT LABORATORIES | Sales & Marketing | - |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - |
Formación de Ginny Blocki.
Indiana University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
ABBOTT LABORATORIES | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
EMBECTA CORP. | Health Technology |
Empresas privadas | 2 |
---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Ginny Blocki